Traws Pharma, Inc. (TRAW) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2010: -$108.72M2011: -$138.42M2012: -$158.31M2013: $80.90M2014: $23.62M2015: $10.84M2016: $5.13M2017: -$10.86M2018: $5.39M2019: $11.57M2020: $6.17M2021: $46.12M2022: $28.31M2023: $10.67M2024: -$31.63M2025: -$629.0K-$629.0K
2010Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$629.0K+98.0%
2024-$31.63M-396.4%
2023$10.67M-62.3%
2022$28.31M-38.6%
2021$46.12M+646.9%
2020$6.17M-46.6%
2019$11.57M+114.9%
2018$5.39M+149.6%
2017-$10.86M-311.8%
2016$5.13M-52.7%
2015$10.84M-54.1%
2014$23.62M-70.8%
2013$80.90M+151.1%
2012-$158.31M-14.4%
2011-$138.42M-27.3%
2010-$108.72M